Latest filing published 12 Aug 2025 for Collegium Pharmaceutical, INC, €343k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
John Gordon Freund, listed as board member, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in SI-BONE, Inc. and Collegium Pharmaceutical, Inc. Over a trading history stretching from 20 May 2021 to 8 August 2025, the count stands at 17 filings.
Every open-market trade on record is a sale: 6 sales worth €3.6M. Other entries cover 10 share grants and 1 option exercise. In 2025 alone, the filings show no purchases and 2 sales.
The newest entry dates from 12 August 2025: an open-market sale of €343k, in Collegium Pharmaceutical, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
17 of 17 declarations